The editors of BMC Women’s Health have officially retracted a published prospective, double-blinded randomized controlled trial that evaluated the clinical value of injecting platelet-rich plasma into the vaginal mucosa for patients presenting with vulvovaginal atrophy.
Following the publication of the original manuscript, substantial concerns were formally brought forward concerning major discrepancies between the trial’s formal clinical trial registration and the experimental procedures detailed in the journal report. The identified discrepancies were broad in scope, notably involving differences in the overall number of enrolled participants, alterations across designated study phases, modifications to patient follow-up schedules, and substantial variations in the specific methodology utilized for evaluating clinical outcomes.
Subsequent editorial inquiries also uncovered significant questions surrounding the underlying authenticity of the statistical data presented in multiple sections of the article. A detailed analysis of the available source material revealed marked numerical inconsistencies between the calculated values and the reported figures for means and standard deviations across Tables 2, 3, 4, and 5, as well as Figure 4 of the paper.
Upon request from the journal’s editorial team, the study’s authors supplied a portion of their underlying source records to clarify the identified statistical and procedural issues. However, the journal concluded that the submitted material remained insufficient to properly resolve the discrepancies or verify the integrity of the published datasets, leading editors to conclude that they could no longer maintain confidence in the findings or conclusions.
Because the editorial board lost confidence in the reliability of the reported outcomes and final clinical conclusions, the publication retracted the article in November 2026.
Subject of Research: Retraction of a randomized controlled trial evaluating platelet-rich plasma for vulvovaginal atrophy
Article Title: Retraction Note: Value of injection of plasma-rich platelets in the vaginal mucosa in cases with vulvovaginal atrophy: a prospective double-blinded randomized controlled study
Article References: Hamid, A. S. A., AbdAllah, A. M., Fathi, H. M., Eldin, A. M. B., & el Hadi, R. M. M. A. (2026). Retraction Note: Value of injection of plasma-rich platelets in the vaginal mucosa in cases with vulvovaginal atrophy: a prospective double-blinded randomized controlled study. BMC Women's Health, 26(1), Article 593. https://doi.org/10.1186/s12905-026-05095-6
Image Credits: AI Generated
DOI: 10.1186/s12905-026-05095-6
Keywords: BMC Women's Health, retraction note, vulvovaginal atrophy, plasma-rich platelets, platelet-rich plasma, vaginal mucosa injection, randomized controlled trial, clinical trial registration, participant numbers, study phases, follow-up schedules, outcome evaluation, statistical data authenticity, means and standard deviations, source data analysis, Ahmed Sherif Abdel Hamid, scientific publishing ethics
News Source: Ophelia Keating. (November 16, 2026). Journal Retracts Vaginal Platelet Trial Over Inconsistent Data and Registration Discrepancies. Scienmag.



